Matteo Delle Vergini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Matteo Delle Vergini has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Alessandro Marchioni
University Hospital of Modena, Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University of Modena Reggio Emilia, Modena, Italy
2 shared publications - Bianca Beghè
Department of Medical and Surgical Sciences, Section of Respiratory Diseases, University of Modena and Reggio Emilia
2 shared publications - Enrico Clini
Centre for Rare Lung Diseases, Pneumology Unit, Department of Medical and Surgical Sciences, ERN-Lung Core Network ILD, University Hospital of Modena—Policlinico, University of Modena and Reggio Emilia, 41121 Modena, Italy
2 shared publications - Roberto Tonelli
Respiratory Diseases Unit, Department of Surgical and Medical Sciences for Children and Adults, University Hospital of Modena, University of Modena and Reggio Emilia, Modena, Italy
2 shared publications - Stefania Cerri
Centre for Rare Lung Diseases, Pneumology Unit, Department of Medical and Surgical Sciences, ERN-Lung Core Network ILD, University Hospital of Modena—Policlinico, University of Modena and Reggio Emilia, 41121 Modena, Italy
2 shared publications - Andrea Carzoli
Respiratory Disease Unit, Department of Medical and Surgical Sciences of Motherhood and Child, University Hospital of Modena, 41125 Modena, Italy
1 shared publication
Latest Publications
- 28 August 2026
- Published by Elsevier in Respiratory Medicine and Research
- Vol. 90, 101318
Non-invasive ventilation during severe asthma exacerbation: Physiological rationale, current evidence, and practical approach
- 28 August 2026
- Published by Elsevier in Respiratory Medicine and Research
- Vol. 90, 101318
Non-invasive ventilation during severe asthma exacerbation: Physiological rationale, current evidence, and practical approach
- Open Access
- 24 March 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (7) , 2205
The Link Between Sleep-Related Breathing Disorders and Idiopathic Pulmonary Fibrosis: Pathophysiological Mechanisms and Treatment Options—A Review
In recent years, several studies have examined the impact of sleep-disordered breathing (SBD) on the quality of life and prognosis of patients with idiopathic pulmonary fibrosis (IPF). Among these disorders, obstructive sleep apnea (OSA) and nocturnal hypoxemia (NH) are the most prevalent and extensively studied, whereas central sleep apnea (CSA) has only been documented in recent research. The mechanisms underlying the relationship between IPF and SBDs are complex and remain an area of active investigation. Despite growing recognition of SBDs in IPF, no standardized guidelines exist for their management and treatment, particularly in a population characterized by distinct structural pulmonary abnormalities. This review outlines the pathophysiological connections between sleep-breathing disorders (SBDs) and idiopathic pulmonary fibrosis (IPF), as well as current therapeutic options. A comprehensive literature search using PubMed identified relevant studies, confirming the efficacy of CPAP in treating severe OSA and CSA. While high-flow oxygen therapy has not been validated in this patient cohort, it may offer a potential solution for select patients, particularly the elderly and those with low compliance. Conventional oxygen therapy, however, is limited to cases of isolated nocturnal hypoxemia or mild central sleep apnea.
- 24 March 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (7) , 2205
Open AccessThe Link Between Sleep-Related Breathing Disorders and Idiopathic Pulmonary Fibrosis: Pathophysiological Mechanisms and Treatment Options—A Review
In recent years, several studies have examined the impact of sleep-disordered breathing (SBD) on the quality of life and prognosis of patients with idiopathic pulmonary fibrosis (IPF). Among these disorders, obstructive sleep apnea (OSA) and nocturnal hypoxemia (NH) are the most prevalent and extensively studied, whereas central sleep apnea (CSA) has only been documented in recent research. The mechanisms underlying the relationship between IPF and SBDs are complex and remain an area of active investigation. Despite growing recognition of SBDs in IPF, no standardized guidelines exist for their management and treatment, particularly in a population characterized by distinct structural pulmonary abnormalities. This review outlines the pathophysiological connections between sleep-breathing disorders (SBDs) and idiopathic pulmonary fibrosis (IPF), as well as current therapeutic options. A comprehensive literature search using PubMed identified relevant studies, confirming the efficacy of CPAP in treating severe OSA and CSA. While high-flow oxygen therapy has not been validated in this patient cohort, it may offer a potential solution for select patients, particularly the elderly and those with low compliance. Conventional oxygen therapy, however, is limited to cases of isolated nocturnal hypoxemia or mild central sleep apnea.